BOSTON: Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance patient health, announced the execution of a definitive merger agreement under which it will be acquired by EQT IX fund and the private equity business within Goldman Sachs Asset Management from Pamplona Capital Management LP…